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ABSTRACT 
Nongenomic in vitro effects of aldosterone on the sodium-proton 
antiport and intracellular second messengers have been described in 
human mononuclear leukocytes, vascular smooth muscle cells, and 
endothelial cells. To test the potential physiological relevance of these 
effects, an in uiuo ‘lP magnetic resonance spectroscopy study on the 
human calf at rest and during exercise was performed in 10 healthy 
volunteers receiving either 1 mg aldosterone or placebo iv in a double 
blind, randomized, cross-over trial. Spectra were analyzed for phos- 
phocreatine, ATP, phosphomonoesters, inorganic intracellular phos- 
phate, and intracellular pH. Resting values remained unchanged by 
R ECENTLY, rapid in vitro effects of aldosterone on the sodium, potassium, and calcium concentrations and 
cell volume of human mononuclear leukocytes (HML) (l-3) 
and on the activity of the sodium-proton exchanger of the cell 
membrane in HML and vascular smooth muscle cells (4-6) 
have been demonstrated. These effects are not compatible 
with an action via classical type I mineralocorticoid receptors 
and suggest the existence of distinct receptors subsequently 
described in plasma membranes from HML and pig kidney 
and liver (7-9). The phosphoinositide pathway, protein ki- 
nase C, and free intracellular calcium appear to be involved 
in intracellular signaling in HML and vascular smooth mus- 
cle cells (4, 10-12). For example, the second messenger, in- 
tracellular Ca’+, is consistently increased by aldosterone 
within l-2 min. In vascular smooth muscle cells, calcium is 
released from perinuclear stores, whereas in endothelial 
cells, a predominant increase in subplasmalemmal calcium is 
seen. Effects are half-maximal at physiological concentra- 
tions of free aldosterone (0.1 nmol/L), whereas cortisol is 
inactive up to 0.1 Fmol/L; the classical mineralocorticoid 
antagonist canrenone is ineffective in blocking this action of 
aldosterone (13). 
Nongenomic effects of mineralocorticoids are very rapid, 
Received June 12, 1996. Revision received August 12, 1996. Accepted 
August 14, 1996. 
Address all correspondence and requests for reprints to: Prof. Dr. M. 
Wehling, Institute of Clinical Pharmacology at the Faculty for Clinical 
Medicine Mannheim, University of Heidelberg, 68135 Mannheim, 
Germany. 
*This work was supported by grants from the Deutsche Forschungs- 
gemeinschaft (We 1184/6-l and SC 4/9-4). 
aldosterone. After isometric contraction of the calf (50% body weight 
for 3 min), phosphocreatine recovered to significantly higher levels 
after application of aldosterone compared with placebo. Other pa- 
rameters were not significantly changed by aldosterone. Effects ap- 
peared immediately after isometric contraction and, thus, occurred 
within 8 min of aldosterone administration. They are, therefore, likely 
to represent the first contemporary evidence of nongenomic in uiuo 
effects of aldosterone in man. These findings also point to an involve- 
ment of aldosterone in the acute stress adaptation of cellular oxidative 
metabolism in human muscle physiology. (J Clin Endocrinol Metab 
81: 4296-4300, 1996) 
as opposed to genomic effects, which are characterized by 
a substantial delay. The latency of genomic steroid effects 
corresponds to a long series of subcellular processes, in- 
cluding messenger ribonucleic acid production, messen- 
ger ribonucleic acid modification, translation into pro- 
teins, protein translocation, and /or insertion into 
membranes. Among the earliest genomic effects known in 
the action of mineralocorticoids is the increased rate of 
mouse mammary tumor virus long terminal repeat tran- 
scription, which begins within 30 min and peaks after 3 h 
in a feline renal cell line (14). This process is insensitive to 
cycloheximide, as it does not require new protein synthe- 
sis. Although even more rapid effects of steroids on tran- 
scriptional processes are known (glucocorticoid effects on 
mouse mammary tumor virus long terminal repeat in L tk- 
aprt- cells were first seen after 7.5 min (15), no actino- 
mycin D- or cycloheximide-sensitive effects are known to 
occur within less than 30 min of mineralocorticoid appli- 
cation. This additional delay at the effector levels is prob- 
ably due to the time-consuming translation and processing 
of newly synthesized protein molecules from their site of 
origin to their final location in the cell membrane. 
The physiological and clinical relevance of the rapid non- 
genomic effects is not yet clear. The extent of their response 
to standard stimuli is relatively modest, and they, thus, may 
have been overlooked in related clinical studies. To our 
knowledge, the only in vivo evidence for rapid aldosterone 
action is a study on cardiovascular parameters in man (16) 
and a report on the baroreceptor reflex in the dog (17), which 
demonstrated effects of aldosterone after 5-15 min on pe- 
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ripheral resistance, cardiac index, and spiking activity of 
baroreceptor neurons. 
In the present report, rapid effects of aldosterone were 
assessed by the use of a 40-cm horizontal bore 31P magnetic 
resonance spectrometer, which allows for continuous in viva 
monitoring of markers of aerobic and anaerobic energy me- 
tabolism and cellular acid-base regulation in a human limb. 
The latter parameter was thought to be affected by aldoste- 
rone, as those effects on sodium-proton exchange described 
above may be reflected in intracellular pH. The calf was 
chosen as it complies with the dimensions of the instrument, 
and a relatively large muscle can be monitored in which a 
constant force can be generated. 
Materials and Methods 
Materials 
Aldosterone for human administration was a gift from Parke-Davis 
(Lainate, Italy); it was dissolved in isotonic NaCl (0.5 mg/mL) under 
sterile conditions and verified as pyrogen free. 
Study volunteers 
Ten healthy volunteers (seven men and three women; mean age, 34 -C 
5 yr) were recruited from the German Aerospace Research Establish- 
ment (Cologne, Germany). A history was taken to exclude chronic and 
acute diseases such as hypertension, heart failure, diabetes mellitus, 
drug allergies, infections, or psychiatric disorders. Special care was 
taken to exclude carriers of metal implants or prostheses. Physical ex- 
amination and routine electrocardiogram (12 lead) revealed no abnor- 
malities. The study design was approved by the ethical committee of the 
University of Aachen (Aachen, Germany). 
Laboratory methods 
Venous blood samples were obtained after a minimum of 30 min of 
rest in the supine position in a quiet environment. Blood was collected 
via an indwelling catheter into heparinized containers on ice and im- 
mediately processed. Routine laboratory tests on serum and urine were 
performed by standard methods in a BM/Hitachi 717 (Boehringer 
Mannheim, Mannheim, Germany). Plasma renin and aldosterone were 
determined by RIA kits (Serono Diagnostika, Freiburg, Germany; ERIA 
Diagnostics, Pasteur, France). 
31P magnetic resonance spectroscopy C31P-MRS) 
MR spectra of the right calf were obtained in a 4.7 Tesla 40-cm 
horizontal bore spectrometer (Bruker-Biospec 47/40, Bruker-Medizin- 
technik, Karlsruhe, Germany). The 1H/31P double tuned surface coil 
(5-cm diameter) was placed under the right calf at its largest diameter. 
A specially designed pedal ergometer allows the performance of iso- 
metric foot plantarflexion. The contraction force at the ball of the foot 
was measured continuously and displayed to the subject. Spectra were 
integrated from 64 scans at 20-s intervals. The resonance frequency of the 
pulse was 81 megahertz for 31P. The flip angle was 60” at the center of 
the coil. Spectra were corrected for saturation artifacts. Spectrum anal- 
ysis used a Bruker X32 computer and Bruker software UXNMR. Relative 
changes in the levels of phosphocreatine (PCr), phosphomonoesters 
@‘ME), inorganic phosphate (Pi), and ATP were monitored, with initial 
values set at 100%. Intracellular pH was determined by the chemical shift 
of Pi relative to that of PCr. 
Study design 
The study was designed as a double blind, placebo-controlled, ran- 
domized, cross-over trial. All 10 volunteers were randomly subjected to 
4 tests; 2 (for aldosterone and placebo) were performed at rest, and 2 
during exercise. The examinations at rest and after exercise were per- 
formed on 2 separate days, with a minimum interval of 5 h for washout 
of aldosterone, which has a plasma half-life of less than 30 min (18), after 
iv administration. The 2 test sets were 4 days apart. Before the study, a 
l-mm diameter catheter was placed in the left antecubital vein for blood 
sampling and aldosterone/placebo injection. A two-lead electrocardio- 
gram was continuously monitored throughout the tests, and blood pres- 
sure measurements were performed at 3-min intervals. For the resting 
tests, MR spectra of the right calf were recorded for 3 min to establish 
baseline conditions, followed by aldosterone/placebo injection and an 
observation period of 17 min. 
For exercise tests, the design was the same, except for the period from 
4-7 min after injection, during which the volunteer was instructed to 
press the pedal isometrically at a force of 50% of the body weight. Force 
measurements were communicated to the subject through an electronic 
display, and the volunteer was advised to adjust the efforts to match 
closely the preset tension level. 
Blood sampling was performed at the beginning of the experiment. 
Statistical methods 
The effects of aldosterone were evaluated by the area under the curve 
(AUC) method, with integration of values for the periods indicated. 
Comparisons between the two groups were made using the nonpara- 
metric Wilcoxon test for paired data. For all tests, P < 0.05 was con- 
sidered statistically significant. Primary end points (defined prospec- 
tively) were AUCs and steady state levels of PCr, PME, Pi, pH, and ATI’. 
Results 
Basic clinical characteristics and laboratory parameters are 
shown in Table 1. No subject had pathological values for any 
parameter tested. The increased basal aldosterone level in 
one volunteer (normal upper limit for recumbent position, 
200 pg/mL) may reflect an insufficient time of rest before 
blood sampling. 
Aldosterone applied at rest did not induce any change in 
PCr (Fig. 1) and other phosphate metabolites (not shown). 
Effects of borderline significance were observed for intra- 
cellular pH. The initial resting intracellular pH was 7.03 + 
0.03 in the placebo group and 7.02 2 0.03 in the aldosterone 
group. The measurement in the prestudy period was unsta- 
ble in two subjects, probably reflecting ischemia of the calf 
due to inappropriate positioning in the ergometer; thus, 
these two subjects were excluded from pH analysis. Within 
3 min of application of aldosterone, a tendency toward acid- 
ification was observed, which continued after a brief recov- 
ery up to the end of the experiment (Fig. 1). This change was 
TABLE 1. Clinical characteristics and laboratory parameters of 
the study volunteers 
Parameter Mean 2 SD 
Female/male 317 
Age (yr) 34 2 5 
Wt (kg) 72.6 2 12.8 
Heart rate (beatsjmin) 65.1 ? 9.7 
Systolic BP (mm Ha) 120.9 * 13.7 
Diastolic BP (mm Hg) 
Hematocrit (L/L) 
Nat (mmol/L) 
68.2 ? 13.3 
0.429 5 0.037 
143 2 0.5 
K+ (mmol/L) 
Protein (mg/dL) 
Hemoglobin (g/dL) 
GOT (U/L) 
Creatinine (mg/dL) 
Basal aldosterone (pg/mL), 
upper normal limit 
Basal renin (pg/mL), 
uuner normal limit 
4.15 2 0.09 
7.46 2 0.16 
14.5 2 1.4 
10 5 2 
0.93 2 0.19 
192.0 + 58.0 
200 
12.5 2 1.8 
26 
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FIG. 1. Mean intracellular pH in calf muscles of normal volunteers 
determined by 31P-MRS. At the time indicated, 1 mg aldosterone (0) 
or placebo (0) was given iv. Spectra were recorded at rest (a; n = 8) 
or during isometric contraction (b; n = 10) at 50% of body weight for 
3 min. When analyzed by the AUC method, differences in pH at rest 
(a) were of borderline significance (P < 0.10) for 15-17 min after 
injection. 
of borderline significance for 15-17 min postinjection when 
analyzed by the AUC method (P < 0.10). 
During exercise no difference in the time course of changes 
in intracellular pH was seen with aldosterone (Fig. 1). Fur- 
thermore, PCr remained unaffected by aldosterone at rest 
and during isometric contraction of the calf (Fig. 2). How- 
ever, oxidative PCr recovery was significantly facilitated by 
aldosterone. The first separation of the curves was seen 8 min 
after injection, with a significant difference between AUCs 
from 7-17 min after drug application (Table 2 and Fig. 2; P < 
0.05). When average values from 14-17 min after aldosterone 
application (steady state levels) were compared, aldosterone 
significantly increased PCr levels by 3% above initial resting 
and recovery values in the placebo group (Table 2 and Fig. 
2; P < 0.01). 
This small effect of aldosterone on oxidative PCr recovery 
was even more pronounced in subjects in whom PCr de- 
creased by more than 20% (n = 6) during exercise. In these 
subjects, PCr reached 5% higher steady state levels at the end 
of recovery compared with their initial values and recovery 
levels in the placebo experiment. All females responded by 
PCr decreases of more than 20%. There were no differences 
in PCr levels if compared with men (4.0 k 3.3% in women 
and 3.3 2 2.3% in men, aldosterone ZX. placebo levels). 
In those subjects who maintained exercise almost exclu- 
sively through the aerobic pathway (n = 4), the PCr at the end 
of contraction was not different from the initial resting and 
recovery levels in the placebo group (Table 2 and Fig. 2). 
There were no significant differences for the other primary 
end points tested (ATP, Pi, PME, and Pi, PME, plus ATP), 
both at rest and under stress. The increase in PCr during 
recovery from anaerobic or mixed contraction was, therefore, 
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FIG. 2. Mean phosphocreatine levels (percentage of initial values 
averaged for 3 min before aldosterone injection) in calf muscles of 
normal volunteers determined by 31P-MRS. At the time indicated, 1 
mg aldosterone (0) or placebo (0) was given iv. Spectra were recorded 
at rest (a; n = 8) or during isometric contraction (b; n = 10) at 50% 
of body weight for 3 min. Results from b were assigned to two groups 
according to the decrease in PCr during contraction (c: APCr >20%; 
n = 6; d: APCr <20%; n = 4). For both the total number of volunteers 
and volunteers with APCr greater than 20%, AUCs were significantly 
different between aldosterone and placebo tests from 7-17 min after 
drug administration (b and c; P < 0.05). Dotted lines are drawn at 
100% (initial level) and additionally in c at the mean level during 
recovery from stress after aldosterone administration. 
not compensated by a decrease in visible internal stores of 
phosphates. Arterial pressure and heart rate remained es- 
sentially constant throughout the tests, although both he- 
modynamic indexes tended to increase during physical 
stress. 
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TABLE 2. Comparison of PCr recovery in normal subjects after injection of 1 mg aldosterone or placebo and isometric exercise (50% body 
weight for 3 min) by the area under the curve method (AUC; 7-17 min after injection) and steady state PCr at the end of recovery (14-17 
min after injection) 
AUC from 7-17 min after injection Average of steady state levels from 14-17 min after injection 
Subject no. (sum of % of initial values; % X min) (lo of initial values) 
Aldosterone Placebo Difference Rank no. (2) Aldosterone Placebo Difference Rank no. (2) 
1” 3247 3105 142 10 (+I 106.1 99.9 6.2 10 (+) 
2 3084 3018 66 6 (+) 101.2 97.6 3.6 7 C-t) 
3 3089 3078 11 2 (+I 100.6 100.5 0.1 1 C-t) 
4” 3140 3070 70 7 (+) 107.0 101.3 5.7 9 (+I 
5 3099 3107 -8 1 C-1 101.0 100.6 0.4 4 (+) 
6” 3167 3089 78 8(+) 103.7 100.6 3.1 6 (+I 
7” 3180 3086 94 9(+) 105.2 99.7 5.5 8 (+I 
8” 3144 3110 34 4(+) 103.5 103.3 0.2 2 (+I 
9 3099 3130 -31 3 (-) 100.3 100.6 -0.3 3 C-1 
10” 3150 3094 56 5 (+) 103.1 102.0 1.1 5 (+I 
AveragetsD 3140 2 50 3089 t 30 51 k 51 P < 0.05 103.2 k 2.4 100.6 2 1.5 2.6 i- 2.6 P < 0.01 
n PCr decreased by more than 20% under resting levels during contraction. 
Discussion 
The main finding of this paper is the demonstration of a 
rapid effect of 1 mg aldosterone, iv, on the recovery of PCr 
after exercise in the calf of healthy volunteers. Increased ATP 
turnover induced by workload alone was insufficient to pre- 
cipitate the changes observed, and utilization of the addi- 
tional anaerobic pathway was required. Given a circulation 
time of 2 min after injection, this effect was observed within 
6 min after the time aldosterone had potentially reached 
peripheral effector sites. Earlier effects of aldosterone on PCr 
could not be tested in this study, as the substantial variability 
in PCr breakdown during exercise would have covered mi- 
nor steroid effects. Whether aldosterone affected muscles at 
rest remains questionable. In the experiments performed 
exclusively at rest, the levels of phosphate metabolites did 
not change; the minute extent of acidification observed after 
aldosterone was of only borderline significance. 
The time frame of the aldosterone effect on PCr after re- 
covery from exercise certainly is consistent with that of non- 
genomic steroid action. As previously mentioned, genomic 
steroid action is characterized by a typical delay at the ef- 
fector level by 1-2 h. The earliest genomic effects known in 
the action of mineralocorticoids on in vitro systems have 
required at least 30 min after hormone application (16, 17). 
In this context, the findings presented here strongly support 
the existence of nongenomic aldosterone effects in viva Such 
effects can be observed in the presence of endogenous hor- 
mone and indicate that the rapid effector is sensitive to 
changes in the aldosterone concentration and is not com- 
pletely and invariably turned on. The comparably high dose 
of aldosterone (8- to IO-fold the daily production of the 
hormone) was chosen to result in maximal effects, as small 
effects were expected, and to minimize delays from hormone 
transport to potential receptors. With regard to the exact 
mechanisms involved, it should be mentioned as a note of 
caution that the rapid actions of aldosterone observed in vitro 
(see above) and those observed here do not necessarily de- 
pend on the same mechanisms. 
Unlike those in vitro studies cited above, in the present in 
vivo investigation, the lack of an antagonist activity of clas- 
sical antimineralocorticoid compounds (e.g. spironolactone) 
was not shown, which, as in those in vitro studies cited above, 
would clearly indicate an involvement of receptors other 
than type I receptors. Therefore, there is still the possibility 
that protein-protein interactions of classical steroid receptors 
that do not require time-consuming protein synthesis may be 
involved in those effects reported here. 
The significance of a very early paper (16) describing in 
vivo effects of aldosterone after 5 min in humans may be 
limited, as the methods used at that time are perhaps open 
to question. The effects in the more recent study on the dog 
(17) were obtained after 15 min, a time at which the sepa- 
ration of nongenomic and genomic effects merely on time 
criteria might not be as convincing as that for 6 min effects. 
In addition, spironolactone blocked this effect, although the 
data presented did not unequivocally support this conclu- 
sion. This finding is in conflict with a previous report on the 
nongenomic aldosterone effects mentioned above (13). 
There are few reports on a relation between exercise and 
plasma aldosterone levels. Increased plasma aldosterone lev- 
els have been found immediately after exhaustive exercise 
(e.g. treadmill exercise at levels >50% maximum oxygen 
uptake). Levels were positively correlated to the extent of the 
workload, thus possibly reflecting increased volume de- 
mand (19-22). Physical endurance training, however, does 
not affect plasma aldosterone levels at rest or after exercise 
stress. These findings have been discussed in context of the 
highly significant effects of endurance exercise training on 
plasma fluid volume regulation during rest and acute exer- 
cise stress. Hespel et al. (22) concluded that physical training, 
leading to a substantial gain of physical working capacity, 
may suppress the plasma renin-angiotensin-aldosterone sys- 
tem in man, thereby counteracting stress-induced increases. 
As the former studies focused on the role of aldosterone 
in stress-related volume regulation, it seems remarkable that 
an independent effect of aldosterone on cellular energy me- 
tabolism in working skeletal muscle was demonstrated here. 
Most key enzymes of energy metabolism are controlled by 
ADP and the ADP/ATP ratio. In muscle fibers, ADP is de- 
termined by the phosphocreatine kinase reaction. After 
stress, aldosterone application increases PCr, whereas Pi, 
ATP, and intracellular pH remain constant. This may reflect 
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an increased potential to activate oxidative and/or glycolytic 
ATP formation during additional periods of work. Conse- 
quently, plasma aldosterone may be involved in an adapta- 
tion mechanism that improves the ATP supply and prevents 
muscle from early metabolic fatigue during endurance ex- 
ercise. However, this speculation must be confirmed by fur- 
ther studies. 
Small changes in PCr can largely affect phosphorylation 
potential and free energy of ATP through the creatine kinase 
reaction. Therefore, even changes that small may have con- 
siderable implications for oxidative phosphorylation and en- 
ergy fueling (23). 
Increased PCr after aldosterone indicates either an uptake 
of external phosphate or a dissociation of phosphate bound 
to macromolecules in the cell because the levels of the other 
free intracellular phosphates (Pi, PME, ATP, and their sum, 
Pi + PME + ATP), did not change. A change opposite that 
in PCr would have been expected if PCr generation would 
have been fueled from the free intracellular phosphate pool. 
The cellular mechanisms of the effect observed here need 
to be explored further on the basis of the in vitro data dis- 
cussed above. A rapid aldosterone receptor / effector may be 
present in skeletal muscle fibers, which has not yet been 
shown in this tissue in vitro. Cellular activation may include 
a rise in the levels of intracellular calcium, sodium, and 
probably protons, leading to metabolic activation and re- 
sulting in an accelerated regeneration of phosphocreatine 
stores. This hypothesis is consistent with the sparse in uivo 
observations, all of which indicate that aldosterone is a stress 
hormone evoking acute circulatory and muscular effects. In 
addition, the method used here appears to be a suitable tool 
for a more extensive in vim exploration of hormonal regu- 
lation of skeletal muscle energy metabolism through various 
hormones, including other steroids and drugs in humans, 
which is still widely lacking. 
Taking the findings of this study and those few reports on 
the rapid in viva action of aldosterone together, a patchy 
sketch of the physiology of aldosterone as a stress hormone 
may be drawn. Postural changes or exercise, which are 
known conditions of a rapid stimulation of aldosterone se- 
cretion, result in increases in vascular tone, especially of 
veins, and/or increases in cardiac output by elevated preload 
and heart rate. These rapid cardiovascular effects of aldo- 
sterone probably occur in uiuo through the action on intra- 
cellular second messengers, such as calcium in vascular 
smooth muscle and endothelial cells, resulting in increased 
vascular tone and / or reduced baroreceptor depressor activ- 
ity. Stimulatory effects on energy metabolism in skeletal 
muscle would facilitate the generation of adequate fueling, 
e.g. for prolonged aerobic contraction of calf muscles, which 
is important for venous blood return in the upright position 
and, possibly, for support of ventilatory muscles. 
In conclusion, rapid in viva changes in intracellular phos- 
phocreatine by aldosterone are fully compatible with earlier 
observations of nongenomic in vitro effects on intracellular 
second messengers and the sodium-proton exchanger. These 
observations underline the potential physiological and, per- 
haps, the clinical relevance of nongenomic steroid effects. 
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